Results
21
21 companies
Medtronic
Market Cap: US$115.9b
Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
MDT
US$90.13
7D
-3.4%
1Y
8.3%
Tempus AI
Market Cap: US$8.8b
Operates as a healthcare technology company.
TEM
US$59.00
7D
18.3%
1Y
n/a
Lantheus Holdings
Market Cap: US$6.7b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$99.44
7D
-3.2%
1Y
68.5%
Guardant Health
Market Cap: US$5.7b
A precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.
GH
US$46.74
7D
9.0%
1Y
172.9%
RadNet
Market Cap: US$3.6b
Provides outpatient diagnostic imaging services in the United States and internationally.
RDNT
US$51.83
7D
5.7%
1Y
10.2%
Veradigm
Market Cap: US$763.1m
A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
MDRX
US$4.25
7D
-15.3%
1Y
-43.3%
CeriBell
Market Cap: US$732.4m
Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.
CBLL
US$21.05
7D
2.8%
1Y
n/a
Nano-X Imaging
Market Cap: US$354.1m
Develops a commercial-grade tomographic imaging device with a digital X-ray source.
NNOX
US$6.12
7D
5.0%
1Y
-37.2%
Guerbet
Market Cap: €327.8m
Engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions.
GBTP
€30.03
7D
0%
1Y
n/a
Light AI
Market Cap: US$67.3m
A healthcare company, focuses on developing artificial intelligence health diagnostic solutions.
OHCF.F
US$0.34
7D
0%
1Y
n/a
Renalytix
Market Cap: US$29.8m
Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.
RENX.F
US$0.091
7D
0%
1Y
n/a
Renalytix
Market Cap: US$29.8m
Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.
RNLX.Y
US$0.26
7D
24.3%
1Y
-71.9%
Spectral AI
Market Cap: US$33.2m
An artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States.
MDAI
US$1.49
7D
-15.3%
1Y
-36.1%
Acarix
Market Cap: US$286.7m
A medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out.
ACIX.F
US$0.03
7D
8.9%
1Y
n/a
OneMedNet
Market Cap: US$15.1m
Provides clinical imaging solutions.
ONMD
US$0.58
7D
-11.7%
1Y
-21.2%
America Great Health
Market Cap: US$10.6m
Operates as a biotechnology company in the United States.
AAGH
US$0.0005
7D
0%
1Y
-86.8%
TrivarX
Market Cap: US$7.9m
A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
MDBI.F
US$0.0021
7D
0%
1Y
n/a
IQ-AI
Market Cap: US$2.7m
Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States.
IQAI.F
US$0.02
7D
0%
1Y
n/a
HeartSciences
Market Cap: US$3.1m
A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.
HSCS
US$2.96
7D
-1.3%
1Y
-75.3%
Aspira Women's Health
Market Cap: US$1.5m
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.
AWH
US$0.095
7D
-27.3%
1Y
-97.3%
EvokAI Creative Labs
Market Cap: US$874.6k
A MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector.
OKAI.F
US$0.17
7D
0%
1Y
n/a